|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the PTIE 10-K filed Feb 13, 2009. Preferred Stock Our Board of Directors has the authority to issue preferred stock in one or more series and to fix the rights, preferences, privileges, restrictions and the number of shares constituting any series or the designation of the series. We have a stockholder rights plan designed to guard against partial tender offers and other coercive tactics to gain control of the Company without offering a fair and adequate price and terms to all of the Company’s stockholders. Pursuant to the stockholder rights plan, our Board of Directors declared and paid a dividend of one right to purchase one one-thousandth share of the Company’s Series A Participating Preferred Stock for each outstanding share of our common stock. Each of these rights entitles the registered holder to purchase from us one one-thousandth of a share of Series A Preferred at an exercise price of $40.00, subject to adjustment at any time.
50
Table of ContentsPAIN THERAPEUTICS, INC. NOTES TO FINANCIAL STATEMENTS—(Continued)
Preferred Stock the number of shares constituting any series or the designation of the series. We have a stockholder rights plan designed to guard against
50 Table of ContentsPAIN THERAPEUTICS, INC. ALIGN="center">NOTES TO FINANCIAL STATEMENTS—(Continued)
These excerpts taken from the PTIE 10-K filed Feb 13, 2008. Preferred Stock Our Board of Directors has the authority to issue preferred stock in one or more series and to fix the rights, preferences, privileges, restrictions and the number of shares constituting any series or the designation of the series. In 2005, our Board of Directors adopted a stockholder rights plan designed to guard against partial tender offers and other coercive tactics to gain control of the Company without offering a fair and adequate price and terms to all of Pain Therapeutics’ stockholders. Pursuant to the stockholder rights plan, our Board of Directors declared and paid a dividend of one right to purchase one one-thousandth share of the Company’s Series A Participating Preferred Stock for each outstanding share of our common stock. Each of these rights entitles the registered holder to purchase from us one one-thousandth of a share of Series A Preferred at an exercise price of $40.00, subject to adjustment at any time.
50
Table of ContentsPAIN THERAPEUTICS, INC. NOTES TO FINANCIAL STATEMENTS—(Continued)
Preferred Stock Our control of the Company without offering a fair and adequate price and terms to all of Pain Therapeutics’ stockholders. Pursuant to the stockholder rights plan, our Board of Directors declared and paid a dividend of one right to purchase one one-thousandth share of the Company’s Series A Participating Preferred Stock for each outstanding share of our common stock. Each of these rights entitles the registered holder to purchase from us one one-thousandth of a share of Series A Preferred at an exercise price of $40.00, subject to adjustment at any time.
50 Table of ContentsPAIN THERAPEUTICS, INC. ALIGN="center">NOTES TO FINANCIAL STATEMENTS—(Continued)
This excerpt taken from the PTIE 10-K filed Feb 26, 2007. Preferred Stock Our Board of Directors has the authority to issue preferred stock in one or more series and to fix the rights, preferences, privileges, restrictions and the number of shares constituting any series or the designation of the series.
48
Table of ContentsPAIN THERAPEUTICS, INC. NOTES TO FINANCIAL STATEMENTS—(Continued)
In 2005, our Board of Directors adopted a stockholder rights plan designed to guard against partial tender offers and other coercive tactics to gain control of the Company without offering a fair and adequate price and terms to all of Pain Therapeutics’ stockholders. Pursuant to the stockholder rights plan, our Board of Directors declared and paid a dividend of one right to purchase one one-thousandth share of the Company’s Series A Participating Preferred Stock for each outstanding share of our common stock. Each of these rights entitles the registered holder to purchase from us one one-thousandth of a share of Series A Preferred at an exercise price of $40.00, subject to adjustment at any time. This excerpt taken from the PTIE 10-K filed Feb 24, 2006. Preferred Stock
Our Board of Directors has the authority to issue preferred stock in one or more series and to fix the rights, preferences, privileges, restrictions and the number of shares constituting any series or the designation of the series.
45
Table of ContentsPAIN THERAPEUTICS, INC.
NOTES TO FINANCIAL STATEMENTS—(Continued)
In 2005, our Board of Directors adopted a stockholder rights plan designed to guard against partial tender offers and other coercive tactics to gain control of the Company without offering a fair and adequate price and terms to all of Pain Therapeutics’ stockholders. Pursuant to the stockholder rights plan, our Board of Directors declared and paid a dividend of one right to purchase one one-thousandth share of the Company’s Series A Participating Preferred Stock for each outstanding share of our common stock. Each of these rights entitles the registered holder to purchase from us one one-thousandth of a share of Series A Preferred at an exercise price of $40.00, subject to adjustment at any time.
This excerpt taken from the PTIE 10-K filed Feb 16, 2005. Preferred Stock
Our Board of Directors has the authority to issue preferred stock in one or more series and to fix the rights, preferences, privileges, restrictions and the number of shares constituting any series or the designation of the series.
| EXCERPTS ON THIS PAGE:
|
| |||||||
